Search

Displaying results 6961 - 6970 of 10000 in total
  1. Drug

    UB-612

    go.drugbank.com/drugs/DB16444
    Investigational

    The vaccine incorporates a strong S1-RBD component linked to a single chain fragment region (sFC) of a human IgG1, which facilitates cell attachment and acts as the principal neutralizing domain of the … The UB-612 COVID-19 vaccine was developed by United Biomedical Inc Asia in Taipei as the first COVID-19 “multi-tope” protein-peptide vaccine made up of eight rationally designed components[L30653].

  2. Drug

    Zinpentraxin alfa

    go.drugbank.com/drugs/DB14852
    Investigational

    Zinpentraxin alfa is a recombinant form of PTX-2, a naturally circulating human protein. … It is under investigation in clinical trial NCT01981850 (A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis).

  3. Drug

    Octopamine

    go.drugbank.com/drugs/DB13251
    Experimental

    It has been used as a nootropic, and therefore it and all of its enantiomer are prohibited by the World Anti-doping Agency (WADA) as of 2014.

  4. Drug

    Trebananib

    go.drugbank.com/drugs/DB12056
    Investigational

    Trebananib is under investigation for the treatment of Ovarian Cancer, Peritoneal Cancer, and Fallopian Tube Cancer. … Trebananib has been investigated for the treatment of Cancer, Oncology, Carcinoma, Metastases, and Colon Cancer, among others.

  5. Drug

    Fuzapladib

    go.drugbank.com/drugs/DB19478
    Experimental

    The usage of the INN stem '-pladib' in the name indicates that Fuzapladib is a phospholipase A2​ inhibitor. Fuzapladib has a monoisotopic molecular weight of 379.12 Da.

  6. Drug

    Umibecestat

    go.drugbank.com/drugs/DB19898
    Experimental

    The usage of the INN stem '-becestat' in the name indicates that Umibecestat is a beta secretase inhibitor. Umibecestat has a monoisotopic molecular weight of 513.08 Da.

  7. Drug

    Tomicorat

    go.drugbank.com/drugs/DB20822
    Experimental

    The usage of the INN stem '-corat' in the name indicates that Tomicorat is a glucocorticoid receptor agonist. Tomicorat has a monoisotopic molecular weight of 527.21 Da.

  8. Drug

    ICX-RHY

    go.drugbank.com/drugs/DB05716
    Experimental

    ICX-RHY is an investigational therapy comprised of cultured allogeneic fibroblasts. … The drug was under investigation in clinical trials in the UK for the treatment of skin erosions in recessive dystrophic epidermolysis bulllosa.

  9. Drug

    Zaloglanstat

    go.drugbank.com/drugs/DB21495
    Experimental

    The usage of the INN stem '-glanstat' in the name indicates that Zaloglanstat is a prostaglandin synthase inhibitor. Zaloglanstat has a monoisotopic molecular weight of 452.12 Da.

  10. Drug

    Zevaquenabant

    go.drugbank.com/drugs/DB21590
    Experimental

    The usage of the INN stem '-nabant' in the name indicates that Zevaquenabant is a cannabinoid receptor antagonist. Zevaquenabant has a monoisotopic molecular weight of 547.11 Da.